A simple, rapid, and sensitive method for isolation and detection of macrolide endectocides (moxidectin, doramectin, selamectin, ivermectin, and eprinomectin) in animal sera and liver is described. Fortified sera or homogenized liver samples were treated with sodium chloride followed by organic solvent extraction. No additional steps were required prior to analysis. Separation of analytes and collection of mass information was achieved by liquid chromatography/mass spectrometry with positive atmospheric pressure chemical ionization set in selected ion monitoring mode with each sample analysis complete in 15 minutes. Presence of each compound was confirmed based on 2 separate extracted ion profiles. Detection of avermectins and moxidectin in a range of working standards was achieved at 10, 50, and 100 ppb. Quantitation of these compounds in fortified samples was based on standard calibration curves with R 2 Ͼ 0.99. Detection limits of 10 ppb for ivermectin, moxidectin, and doramectin, 50 ppb for selamectin, and 100 ppb for eprinomectin were achieved in spiked sera. Recoveries of avermectins and moxidectin in 500 ppb fortified sera fell between 61 and 89% (Ϯ5.7-15.7). Analysis of fortified liver gave comparable results with recovery of selamectin of 83-91% Ϯ 18.3. A complete mass spectral fragmentation pattern of selamectin and affordable screening method for 6 macrolide endectocides are reported. Method comparison for salt treatment and solid-phase extraction of fortified samples is discussed.
Macrolide endectocides are active against both internal and external parasites at very low concentrations. 12 These derivatives of fermentation products of soil-dwelling Streptomyces spp. bacteria are important antiparasitic agents due to their broad spectrum of activity, high potency, and low mammalian toxicity. Although considered to be safe under most conditions of use, intoxication of animals and humans has been reported. 5, 8, 19, 20, 22, 24, 37 In addition, their extralabel use or misuse on food-producing animals may result in violative tissue residues. 4, 26 Because of toxicity and foodsafety concerns, there is increasing interest in method development for detection and quantitation of these drugs in animal matrices.
There are 2 major groups of macrolide endectocides, the avermectins (abamectin, doramectin, eprinomectin, ivermectin, and selamectin) and the milbemycins (moxidectin, from the nemadectin subgroup). Chemical structures for ivermectin, a widely used avermectin in livestock agriculture, and selamectin, a novel endectocide, are shown in Fig. 1 . Both compounds are derivatives of 16-membered pentacyclic lactones. However, unlike selamectin which is a C13-monosaccharide-C5-oxime, ivermectin possesses a C5-hydroxyl group and C13 disaccharide moiety. 6 General structures of eprinomectin, doramectin, and moxidectin re-semble those of ivermectin and selamectin. Due to great structural similarity between these molecules and their closely related antiparasitic properties, all of the compounds mentioned above were included in the present study.
Detection of avermectins and moxidectin can only be addressed after their isolation and purification is achieved. A number of different techniques dealing with recovery of avermectins and moxidectin from animal and food matrixes have been previously reported. The most frequently used methods for sample cleanup include solid-phase extraction (SPE) with Florisil, aminopropyl-Bond Elut-C8, or SepPack-C18 cartridges. 1, 2, 15, 25, 28, 29, 31, 38, 39 Other techniques including on-line SPE and column-switching liquid chromatography, 16 as well as immunoaffinity using monoclonal antibodies, have been developed for ivermectin. 25, 35 However, these techniques, while sensitive (detection limit of 2 ppb), are quite laborious. A recent study reported a simplified purification procedure for macrolide endectocides from liver using a single-step alumina-N SPE. 13 However, derivatization of compounds was still required for detection.
Initial studies of macrolide endectocide presence in animal plasma were performed on liquid chromatography with UV detection, but sensitivity of this technique was highly dependent on extensive clean-up procedures. 25, 29 Reverse-phase liquid chromatography utilizing derivatization procedures for macrolide endectocides with fluorescence detection was established and proved to be a more sensitive method for avermectin identification (detection at 0.2-1 ppb). 2, [9] [10] [11] 23, 32, 38 This method has been reported for detection of eprinomectin in bovine liver, kidney, muscle, and fat 28 and for selamectin in dog and cat plasma. 40 Difficulties in derivatization have been addressed with discovery of the sensitivity of eprinomectin to reaction time and temperature. 2, 14 Additional attempts have been made to develop simultaneous determination techniques for a number of different mixtures of avermectins in a large variety of matrices. Liquid chromatography (LC) with fluorescence detection has been applied for multiresidue detection of avermectins and moxidectin in liver, 2, 13, 31 identification of eprinomectin and ivermectin in apples, pears, and tomatoes, 9, 15 and determination of abamectin, doramectin, ivermectin, and moxidectin in milk. 33 With the advent of the interface between LC and mass spectrometry (MS; LC/MS), detection and quantitation of avermectins and moxidectin based on their MS-extracted ion profiles allowed the determination of these compounds at low levels in animal tissues. 21, 41 Mass spectral techniques utilized included electron impact, chemical ionization, and electrospray ionization mass spectrometry. 2, 18, 36 These methods were used to confirm presence of moxidectin in bovine fat at 250 ppb 36 and multiresidue detection of 4 avermectins and moxidectin at 25 ppb in liver. 1 This article proposes a simple, rapid, and sensitive multiresidue method for isolation and detection of moxidectin, doramectin, selamectin, ivermectin, and eprinomectin by LC/MS with positive atmospheric pressure chemical ionization (APCI) set to run in selected ion monitoring (SIM) mode to increase sensitivity of detection. Purification, isolation, and detection are described for all 5 macrolide endectocides at a low ppb levels with no requirements for sample derivatization.
Materials and methods
Materials. Avermectin standards were obtained from the following sources: eprinomectin was a generous gift of James Stedelin II (Centralia Animal Disease Laboratory, Centralia, IL), doramectin and selamectin were a generous gift of Pfizer Central Research a (white powder), ivermectin b was purchased from Sigma. Moxidectin solution was prepared from a 2% (w/v) equine oral gel c obtained as described previously. 5 Acetonitrile (ACN) and sodium chloride (NaCl) were purchased from Fisher Scientific. d All reagents used were high-performance liquid chromatography (HPLC) grade. Acrodisc CR 4-mm syringe filters (0.45-m polytetrafluoroethylene [PTFE] membrane) were purchased from Gelman Laboratories. e C8-Bond Elut LRC columns and Sep-Pak Plus Florisil SPEs were purchased from Varian f and Waters, g respectively.
Preparation of standards. Individual stock standards (1,000 ppm) of eprinomectin, doramectin, selamectin, and ivermectin were prepared by dissolving 10.0 mg of each avermectin in 10 ml of ACN using a 10-ml volumetric flask. To obtain 1,000 ppm stock standard of moxidectin, the 2,000 ppm moxidectin standard 5 was diluted 1:1 with ACN. A 10 ppm working standard mix was prepared by combining 10 l of each 1,000 ppm stock standard with 950 l ACN. A range of all other working standard mixtures (1,000, 500, 50, and 10 ppb) was prepared by a serial dilution of the 10 ppm standard mix. All samples were stored at 4 C without noticeable degradation of these compounds for a period of 1 yr.
Sample extraction. Sample preparation technique varied based on the sample source. Negative control bovine sera and porcine liver samples not containing detectable amounts of the investigated analytes were analyzed prior to fortification with macrolide endectocides. Aliquots (1 ml) of negative control sera placed in glass tubes were spiked with avermectin working standard mix solution at 2,000-, 500-, 50-, and 10-ppb levels. The solutions were then combined with about 0.2 g of NaCl or enough to saturate the sample after vortexing, then 1 ml of ACN was added to each. For liver samples, 2 g aliquots of tissue in plastic tubes were spiked with the avermectin standard mix at 2,000-, 500-, and 50-ppb levels. Each sample was homogenized with a Bio-Homogenizer h after the addition of 6 ml of ACN. All samples were then vortexed for 15 sec and centrifuged for 8 min at 2,000 ϫ g. Supernatants were transferred to new glass tubes and pellets were washed with an additional 1 or 4 ml of ACN for sera and liver samples, respectively. The collected supernatants were combined for each sample. Serum supernatants were reduced to dryness under nitrogen at 55 C. Liver supernatants were saturated with NaCl and centrifuged. These second supernatants were harvested and reduced to dryness. Residues were resuspended in 500 l of ACN, vortexed for 10 sec, and filtered through 0.45-m PFTE membranes prior to transfer to HPLC vials for analysis.
LC/MS conditions. A series 1100 LC/MSD system i was equipped with a dual LC pump, a diode array detector, a degasser, a column thermostat, an autosampler, and an MS. A Betasil C18-reverse phase column j (4.6 ϫ 250 mm; 5-m particle size) was equilibrated with the mobile phase (98% ACN and 2% double deionized water) prior to analysis. Chromatograms were generated at 254 nm with a spectrum range of 220-310 nm and a range step of 2 nm. The LC profiles were developed at 0.8 ml/min at 45 C with a 0-15min isocratic elution of mobile phase. Injected sample volume for each assay was 20 l. Mass spectrometer conditions were based on previous publications, 1,5 with the following modifications: dry gas flow rate was at 3.0 ml/min and temperature at 325 C, nebulizer pressure was set to 45 psi nitrogen, and vapor temperature was set at 425 C. Fragmentation information for the compounds of interest was acquired with positive APCI after a 5-min solvent delay. Initial studies were performed in the full-scan mode of MS (m/z ion range of 300-1,100) in order to gain representation of the total ion chromatogram for each compound analyzed. To obtain more precise information for detection, the mass spectrometer was set to operate in SIM mode. Ions with m/z of 914 and 897, 622 and 590, 575 and 331 were monitored from 5 to 9 min for eprinomectin, doramectin, and moxidectin, respectively, and ions with m/z of 770 and 608, 551 and 307 were monitored from 9 to 15 min for selamectin and ivermectin, respectively. The individual extracted ions had corresponding retention times of 6.2, 7.3, 8.4, 10.2, and 11.0 min for eprinomectin, moxidectin, doramectin, selamectin, and ivermectin, respectively.
Data evaluation. Individual authentic standards and their mixtures were analyzed under identical conditions prior to analysis of fortified samples. Elution times during LC and individual extracted-ion profiles for a standard mix of avermectins and moxidectin were used to make correct peak assignments for each compound. At least 3 working standard mixes ranging in concentration from 1,000 to 10 ppb were used to construct a standard calibration curve. Extracted ion profiles were obtained for each analyte at 2 corresponding ions in a standard mix with peak areas determined by a standard integrator algorithm i . Each standard curve was based on the peak area versus concentration of the analyte, analyzed by the least-square linear regression and accepted with the correlation coefficient (R 2 ) of 0.99. Percent recovery (%) for 3 replicates (n ϭ 3) of each experiment with corresponding standard deviation for eprinomectin, moxidectin, doramectin, selamectin, and ivermectin in the fortified sera and liver samples (concentration of drugs recovered vs. initial concentration used to spike the samples) was based on the extracted ion peak areas and the individual standard calibration curves. The sample limit of detection was based on the smallest amount of avermectins and moxidectin detected in fortified samples.
Results
Liquid chromatography and ultraviolet profiles for avermectins and moxidectin. Absorbance spectra for all the avermectins and moxidectin were compared at a high concentration level (10 ppm) in order to determine if detection at a single wavelength would suffice. Except for selamectin, with its absorbance maximum at 245 nm, the absorbance profile was the same for the rest of the analytes (maximum at 245 nm and 2 additional shoulders at 235 and 253 nm; data not shown). A typical chromatographic elution profile of avermectins and moxidectin in a 10 ppm working standard mix at 254 nm in shown in Fig. 2 . The retention times for eprinomectin, moxidectin, doramectin, selamectin, and ivermectin were 6.2, 7.3, 8.4, 10.2, and 11.0 minutes, respectively. The peaks were well resolved under isocratic conditions, suggesting that this screening method is specific for the compounds of interest. Lower concentration standard mixes were analyzed under the same conditions with a 5% variation in the peak elution times (data not shown). The ultraviolet (UV) detector of the LC/MS system could not reliably be used with fortified sera samples below 500 ppb. Thus, to allow quantitation below this level, mass spectral profiles were obtained for all the standards and samples (see later).
Mass spectral multiresidue detection of avermectins and moxidectin. In order to obtain a complete representation of fragmentation patterns of each pure av- Table 1 . * Fragmentation analysis was performed by positive APCI MS in a scan mode for a 10-ppm standard mixture. The remaining fragmented ions generated were omitted for clarity. † Relative abundance for each ion (%). Compounds are listed in order of elution from LC/MS. ermectin and moxidectin so that these compounds could be unambiguously identified in SIM, mass spectral data for a mixture of the 5 analytes involved in this study were collected at 10 ppm each in full-scan mode of MS with positive APCI (m/z range of 300-1,100), and the total ion chromatogram is shown in Fig. 3 (panel A) . The heights of detected peaks for eprinomectin, doramectin, selamectin, and ivermectin are at least 3 times that of the signal-to-noise ratio (S/ N; instrument background detection). Fragmentation patterns for eprinomectin and moxidectin obtained using positive APCI MS in a scan mode resulted in generation of the corresponding parental ions and loss of water ions, in good agreement with previously reported data. 3, 36 The 2 parent ions ([MϩH] ϩ ) with m/z at 914 (35%) and 640 (20%, not shown) were at a lower abundance than the [MϩH-H 2 O] ions at m/z at 896 (40%) and 622 (100%) and corresponded to eprinomectin and moxidectin, respectively (Table 1 ). Ivermectin had a very similar pattern to that reported pre-viously (data not shown), with the predominant ion at m/z at 551. 1 The full-scan mass spectrum was established for each peak (data not shown), with the corresponding fragmentation pattern for selamectin reported in Fig. 3 (panel B) . The parent ion for selamectin was detected at m/z 770.6 ([MϩH] ϩ ) with 100% abundance. The additional fragmentation resulted in ions with m/z of 626.5, 608.4, 590.5, 333.3, and 315.2, with abundances at least 3 times the S/N. A summary of 2 significant characteristic ions for the 4 avermectins and moxidectin and their relative abundances seen at 10 ppm are reported in Table 1 .
Detection of avermectins and moxidectin in fortified sera and liver. Control bovine sera and porcine liver samples were spiked at 5 different concentrations of a standard mix of avermectins and moxidectin: 500, 300, 100, 50, and 10 ppb. Samples were extracted and analyzed by the method described above. The chromatogram for a spiked serum sample at 500 ppb of avermectins and moxidectin (Fig. 4) clearly demonstrates that the peak behavior and elution pattern are the same as the profile of the standard working mixture (Fig. 2) . No UV signal was observed for spikes at lower concentrations (data not shown). The absence of matrix interferences and the clean peak resolution seen in Fig.  4 suggest that sufficient sample purification was achieved by salt treatment and organic extraction. A similar behavior was seen for fortified liver samples (data not shown). Detection of analytes at or below 500 ppb was done by MS in the positive APCI/SIM mode. A set of ions listed in Table 1 (data not shown) was followed for individual avermectins and moxidectin. Most peaks examined were detected with abundance at least 3 times the observed background. Figure Extracted ion profiles for the corresponding secondary ions for each analyte were the same and could be used for conformation of identity ( Table 2 , data not shown). Analysis of sera samples fortified at 2 different levels resulted in the overall average recoveries of 85.2% (Ϯ12.7) and 82.7% (Ϯ14.3) for moxidectin and ivermectin, respectively (calculated based on data in Table 2 ). Overall recoveries for eprinomectin, doramectin, and selamectin fell between 62.1 and 78.8%, with standard deviation averaging at Ϯ12.6. Eprinomectin was detected and quantitated in 100 ppb fortified serum as shown in Fig. 5B (63.7% average sample recovery; Table 2 ) and in 300 ppb spiked liver (66.2% Ϯ 12.8 average sample recovery; data not shown). The same type of experiment was completed for the liver samples, and a comparison of average sample percent recovery was made between the 2 matrixes. Liver fortified with all the analytes at 500 ppb (n ϭ 3) resulted in the average percent recovery of 74.8% (Ϯ9.5), 89.2% (Ϯ15.5), and 35.9% (Ϯ14.9) for eprinomectin, selamectin, and moxidectin, respectively. Difficulties were seen with detection of doramectin and ivermectin at m/z 331 and 307; however, quantitation was possible at m/z 575 (41.9% Ϯ 12.1) and 551 (71.8% Ϯ 9.1), respectively (data not shown). Analysis of liver fortified with 100 ppb of selamectin, moxidectin, doramectin, and ivermectin gave comparable results: 84.3% Ϯ 21.0, 29% Ϯ 2.3, 25.4% Ϯ 4.8, and 67.2% Ϯ 11.0, respectively (data not shown).
Additional data was obtained for sera fortified with all the analytes of interest at 10 ppb. No eprinomectin or selamectin were detected, but moxidectin, doramectin, and ivermectin were quantitated at 43, 86, and 93.7% sample recovery at m/z 622, 575, and 551, respectively (data not shown).
Discussion
Macrolide endectocides are popular in livestock agriculture due to their efficacy against a number of in- ternal and external parasites as well as to their safety. They are currently marketed for human, animal, and agricultural crop use. While the safety margin of macrolide endectocides in mammals is wide, there are case reports documenting differences in macrolide endectocides toxicity among species including dogs, 5, 19, 20 cats, 24 nonhuman primates, 22 chelonians, 37 and humans. 8 Reported oral LD 50 (lethal dose for 50% of population) values for ivermectin in mice, rats, and beagle dogs are 25, 50, and 80 mg/kg, 17 respectively. Among dog breeds, certain strains of Collies are more sensitive to central nervous system toxicity associated with their use. 30 Some collie dogs are intoxicated by oral ivermectin doses as low as 0.01-2.5 mg/kg. 27 Despite numerous cases of intoxication, there is little information regarding concentrations of the various endectocides in tissues and body fluids associated with clinical signs. In 1 study of ivermectin toxicity in a sensitive mouse strain, mean drug concentrations in brain, liver, fat (neck), and plasma were 131, 497, 486, and 52 ppb, respectively, following an oral dose of 0.2 mg/kg. 34 The highest concentration (1,376 ppb) was detected in the gall bladder. In a case of moxidectin intoxication in a collie dog, a fat biopsy contained 1,200 ppb but plasma and serum samples were negative (method detection limit Ͻ 100 ppb). 5 The ingested dose was not known. The efficacy and safety of macrolide endectocides has led to a number of extralabel uses. 4, 26 Because of their lipophilicity and persistence in edible tissues and fluids such as fat and milk, extralabel use in the absence of established withdrawal times can lead to residues in food products intended for human consumption. Thus, use of the macrolide endectocides presents both poisoning and human food adulteration risks and justifies the need for rapid and sensitive analytical assays in a variety of sample matrices.
The main tissue site of avermectin biotransformation is liver, with less biotransformation occurring in fat. 7 Primary excretion of avermectins and milbemycins occurs in the feces and bile, with little excretion via urine. Appropriate samples for analysis in suspected cases of intoxication include plasma or serum, fat, and feces antemortem and brain, fat, bile, feces, and perhaps liver from postmortem examination. Meat and milk would be the most likely samples to test for residues in suspected cases of food adulteration.
The present article reports a simple, rapid, and specific method for isolation, detection, and quantitation of 4 avermectins (eprinomectin, doramectin, ivermectin, and selamectin) and moxidectin in 2 matrices. Identity of compounds was determined by their 2 extracted ion profiles (Table 1 ). Setting the method to run in SIM greatly improved sensitivity and selectivity of sample detection. Due to limited fragmentation by APCI, difficulties were observed with detection of both ions for doramectin and ivermectin in 100 ppb fortified liver. However, quantitation was possible based on at least 1 suitable ion, and confirmation of each analyte was accomplished in fortified sera and most liver samples. Salt and organic-phase treatment of fortified samples afforded the simplest sample clean-up method, bypassing the laborious SPE techniques that have been reported as crucial for extraction of avermectins and moxidectin from animal matrices. 1, 2, 13, 15, 25, 28, 31 Quantitation of eprinomectin was accomplished at a slightly higher detection limit than the other compounds analyzed but without any requirement for structural modification, as has been reported by previous publications. 2, 28, 38 Simultaneous detection of ivermectin, moxidectin, and doramectin at 10 ppb in fortified animal sera is the lowest level detected * Matrices were fortified with 500 ppb of eprinomectin and 50 ppb of the other compounds listed. Retention times and specific ions monitored in an LC/MS system are those described in Table 2. while screening by LC/MS with positive APCI to date. 1, 3, 36, 39 In order to further investigate the role of sample clean-up and for reasons of comparison, sera and liver samples fortified at 50 ppb of moxidectin, doramectin, selamectin, and ivermectin and at 500 ppb of eprinomectin were analyzed with 2 different SPE methods. The experiments were performed based on a previously described technique 1 in which the recoveries for the macrolide endectocides were not reported. The method was designed for drug confirmation, with a detection limit of 25 ppb. The described technique using SPE purification with C8-Bond Elut LRC columns f (10 cm 3 /250 mg) was simplified by omitting triethylamine and methylene chloride. 1 Analytes were eluted from the Bond Elut column with 100% ACN, concentrated to 500 l, filtered, and injected onto an LC/MS system. The detection method developed for this study (LC/MS with positive APCI in a SIM mode) was employed for analysis. The loss of analytes during the Bond Elut procedure was apparent when only 18, 10, and 45% sample recoveries were obtained from fortified sera for eprinomectin, selamectin, and ivermectin at m/z 914, 770, and 551, respectively (Table 3) . Similar recoveries were obtained for a liver matrix. A liver sample fortified at 100 ppb ivermectin was analyzed with the Sep-Pak Plus Florisil column g with added alumina. The final sample recovery was calculated at 75% for m/z 551, which was similar to that for the salt treatment procedure described in this article (67.2% Ϯ 11.0).
These results show that sensitive screening of macrolide endectocides in animal sera and liver by LC/MS with positive APCI does not require a complicated and involved purification scheme. The isolation method is simplified and no SPE is required. There is no need for column-switching techniques or specific organic/ buffer systems.
